Prediction of caffeine in tablets containing acetylsalicylic acid, dipyrone, and paracetamol by near infrared spectroscopy, raman scattering, and partial least squares regression

Two chemometric models drawing on diffuse reflectance near infrared spectroscopy and Raman scattering are proposed to predict caffeine content in tablets based on acetylsalicylic acid, dipyrone, and paracetamol contents. However, data mining from these analyses to create models generally requires a prior comparison between spectral data and the results from reference values obtained by analytical methodology. Therefore, the construction of a robust calibration model entails that both analytical methods are simultaneously employed on several samples, which represents a limiting factor for the widespread use of spectroscopy. In this case, grounded tablets of different brands, containing only the active principles acetylsalicylic acid, dipyrone, or paracetamol and their excipients, were doped with controlled amounts of pure caffeine ranging from 0 to 10%(w/w) and used as calibration samples. Thus, caffeine quantification with a reference method was not necessary. The prediction samples had at least one of the aforementioned active ingredients and caffeine in its original formulation. Hence, the %(w/w) values of caffeine used as reference for the prediction steps were calculated from the values described on the drug description leaflet and the tablet final mass. Partial least squares regression was used as a multivariate method to construct the models. The near infrared and Raman prediction models for caffeine, using four latent variables, presented the respective values of 0.79 and 0.78 of root mean square errors of cross validation, 0.74 and 1.00 of root mean square errors of prediction, and 0.97 and 0.97 of correlation coefficients.

1. J. L. Temple, C. Bernard, S. E. Lipshultz, J. D. Czachor, J. A. Westphal, M. A. Mestre, Front. Psy., 8, 1–19 (2017).

2. M. C. Cornelis, Nutrients, 11, 416–420 (2019).

3. A. Shabir, A. Hooton, J. Tallis, M. Higgins, Nutrients, 10, 1528 (2018).

4. D. Wikoff, B. T. Welsh, R. Henderson, G. P. Brorby, J. Britt, E. Myers, J. Goldberger, H. R. Lieberman, C. O’Brien, J. Peck, M. Tenebein, C. Weaver, S. Harvey, J. Urban, C. Doepker, Food Chem. Toxicol., 109, 585–648 (2017).

5. A. Nehlig, J. Daval, G. Debry, Brain Res. Rev., 17, 139–170 (1992).

6. J. Sawynok, Pain, 152, 726–729 (2011).

7. R. P. Heaney, Food Chem. Toxicol., 40, 1263–1270 (2002).

8. A. R. Feinstein, L. Heinemann, D. Dalessio, J. M. Fox, J. Goldstein, G. Haag, D. Ladewig, C. P. O’Brien, Clin. Pharmacol. Ther., 68, 457–467 (2000).

9. H. R. V. Godoy, F. B. Gonçalves, C. F. Moraes, Rev. Med. Saude, 1, 169–173 (2012).

10. V. A. Voicu, C. Mircioiu, C. Plesa, M. Jinga, V. Balaban, R. Sandulovici, A. M. Costache, V. Anuta, I. Mircioiu, Front. Pharmacol., 10, 607 (2019).

11. J. R. Scott, A. L. Hassett, C. M. Brummett, R. E. Harris, D. J. Clauw, S. E. Harte, J. Pain Res., 10, 1801–1809 (2017).

12. J. Cruz, M. Bautista, J. M. Amigo, M. Blanco, Talanta, 80, 473–478 (2009).

13. E. M. Aldred, Pharmacology, a Handbook for Complementary Healthcare Professionals, 41, 331–341 (2009).

14. F. A. C. Sanches, R. B. Abreua, M. J. C. Pontes, F. C. Leite, D. J. E. Costa, R. K. H. Galvão, M. C. U. Araujo, Talanta, 92, 84–86 (2012).

15. C. A. D. Melo, P. Silva, A. A. Gomes, D. D. S. Fernandes, G. Véras, A. C. D. Medeiros, J. Braz. Chem. Soc., 24, 991–997 (2013).

16. M. I. Díaz-Reval, R. Galván-Orozco, F. J. López-Muñoz, N. Carrillo-Munguía, Cir. Ciruj., 76, 241–246 (2008).

17. G. G. Graham, M. J. Davies, R. O. Day, A. M. K. F. Scott, Inflammopharmacology, 21, 201–232 (2013).

18. S. J. Peroutka, J. A. Lyon, J. Swarbrick, R. B. Lipton, K. Kolodner, J. Goldstein, Headache, 44, 136–141 (2004).

19. S. Diamond, T. K. Balm, F. G. Freitag, Clin. Pharmacol. Ther., 68, 312–319 (2000).

20. A. Polski, R. Kasperek, K. Sobotka-Polska, E. Poleszak, Curr. Issues Pharm. Med. Sci., 27, 10–13 (2014).

21. http://portal.anvisa.gov.br/documents/3845226/0/Justificativa_Limites_Suplementos.pdf/e265ccd0-8361-4d8e-a33f-ce8b2ca69424.

22. S. C. Escobar, L. R. Cubides, C. P. Pérez, Indian J. Pharm. Sci., 79, 731–739 (2017).

23. R. C. Lopez-Sanchez, V. J. Lara-Diaz, A. Aranda-Gutierrez, J. A. Martinez-Cardona, J. A. Hernandez, J. Anal. Methods Chem., 2018, 1–11 (2018).

24. M. F. F. Lima, G. I. S. França, D. J. F. Souza, A. G. S. Cabral, C. A. de Azevedo Filho, Braz. J. Health Rev., 2, 4600–4610 (2019).

25. M. Jeszka-Skowron, A. Zgoła-Grzeskowiak, T. Grzeskowiak, Eur. Food Res. Technol., 240, 19–31 (2015).

26. M. C. Sarraguça, A. V. Cruz, S. O. Soares, H. R. Amaral, P. C. Costa, J. A. Lopes, J. Pharm. Biomed. Anal., 52, 484–492 (2010).

27. D. Melucci, D. Monti, M. D’Elia, G. Luciano, J. Forensic Sci., 57, 86–92 (2012).

28. Y. Sacré, F. Chavez, L. Netchacovicth, Ph. Hubert, E. Ziemos, J. Pham. Biomed. Anal., 101, 123–140 (2014).

29. C. S. Silva, A. Braz, M. F. Pimentel, J. Braz. Chem. Soc., 30, 2259–2290 (2019).

30. A. B. Eldin, O. A. Ismaiel, W. E. Hassan, A. A. Shalaby, J. Anal. Chem., 71, 861–871 (2016).

31. M. Palo, K. Kogermann, N. Genina, D. Fors, J. Peltonen, J. Heinämäki, N. Sandler, J. Drug Deliv. Sci. Technol., 34, 60–70 (2015).

32. D. M. Muntean, C. Alecu, I. Tomuta, J. Spectrosc., 2017, 1–8 (2017).

33. Y. Roggo, K. Degardina, P. Margot, Talanta, 81, 988–995 (2010).

34. N. M. Ralbovsky, I. K. Lednev, Spectrochim. Acta A, 219, 463–487 (2019).

35. B. Nagy, A. Farkas, M. Gyurkes, S. Komaromy-Hiller, B. Demuth, B. Szabo, D. Nusser, E. Borbas, G. Marosi, Z. Kristof, Int. J. Pharm., 530, 21–29 (2017).

36. B. M. Wise, N. B. Gallagher, R. Bro, J. M. Shaver, W. Windig, R. S. Koch, PLS_Toolbox 3.5, for Use with MatlabTM, Eigenvector Research (2004).

37. A. Savitzky, M. J. E. Golay, Anal. Chem., 36, 1627–1679 (1964).

38. R. G. Brereton, Applied Chemometrics for Scientists, John Wiley & Sons (2007).

39. J. V. Roque, W. Cardoso, L. A. Peternelli, R. F. Teófilo, Anal. Chim. Acta, 1075, 57–70 (2019).

40. J. S. Ribeiro, M. M. C. Ferreira, T. J. G. Salva, Talanta, 83, 1352–1358 (2011).

41. M. M. Said, S. Gibbons, A. C. Moffata, M. Zloha, Int. J. Pharm., 415, 102–109 (2011).

42. M. Blanco, R. Cueva-Mestanza, A. Peguero, J. Pharm. Biomed. Anal., 51, 797–804 (2010).

43. M. H. Ferreira, J. F. F. Gomes, M. M. Sena, J. Braz. Chem. Soc., 20, 1680–1686 (2009).

44. E. Otsuka, H. Abe, M. Aburada, Drug Dev. Ind. Pharm., 36, 839–844 (2010).

45. I. Pavel, A. Szeghalmi, D. Moringnio, S. Cinta, W. Kiefer, Biopolymers, 72, 25–37 (2003).

46. H. G. M. Edwards, T. Munshi, M. Anstis, Spectrochim. Acta A, 61, 1453–1459 (2005).